A Decade of Single-Center Experience in Children With Congenital Pyriform Sinus Fistula (CPSF)

Tingting Ji1, Ting Long1, Yuwei Liu1

  • 1Department of Otolaryngology, Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

The Laryngoscope
|July 31, 2024
PubMed

Insights

Carbon dioxide (CO2) laser cauterization is a safe and effective treatment for pediatric congenital pyriform sinus fistula (CPSF), showing a low recurrence rate and minimal complications. This method is a viable therapeutic option for managing CPSF in children.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Laser Surgery

Background:

  • Congenital pyriform sinus fistula (CPSF) is a rare condition in children.
  • Surgical management of CPSF can be challenging, with varying outcomes.
  • Minimally invasive techniques are increasingly explored for pediatric surgical conditions.

Purpose of the Study:

  • To evaluate the efficacy and safety of CO2 laser cauterization for pediatric CPSF.
  • To assess long-term outcomes following CO2 laser cauterization.
  • To identify predictors for the number of laser cauterization procedures required.

Main Methods:

  • Retrospective analysis of clinical data from children with CPSF treated with CO2 laser cauterization.
  • Procedures performed using suspension laryngoscopy and microscopy.
  • Multiple logistic regression used to identify predictors of procedure count.

Main Results:

  • 238 children with CPSF were included; 235 achieved successful fistula closure with CO2 laser cauterization.
  • Median follow-up was 6.46 years; only 1.3% experienced recurrence requiring open surgery.
  • Age at first operation was an independent risk factor for the number of procedures; no permanent complications were reported.

Conclusions:

  • CO2 laser cauterization is an effective and safe treatment for pediatric CPSF.
  • The procedure demonstrates a low recurrence rate and minimal complications.
  • CO2 laser cauterization is a recommended therapeutic option for pediatric CPSF management.
Abstract